World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
107
Citations
42989
World Ranking
6243
National Ranking
3332

Michael H. Baumann publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael H. Baumann sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 935 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michael H. Baumann D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael H. Baumann sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 107 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michael H. Baumann is affiliated with the National Institute on Drug Abuse in the United States. Their research focuses on areas within neuroscience and medicine, producing a significant body of work in the fields of cellular and molecular neuroscience, molecular biology, toxicology, clinical psychology, and pharmacology.

The main topics covered in Michael H. Baumann's research include:

  • Neurotransmitter Receptor Influence on Behavior
  • Forensic Toxicology and Drug Analysis
  • Psychedelics and Drug Studies
  • Pharmacological Receptor Mechanisms and Effects
  • Cannabis and Cannabinoid Research
  • Neuroscience and Neuropharmacology Research
  • Chemical synthesis and alkaloids

Some of the frequent publication venues where their work has appeared are:

  • Journal of Pharmacology and Experimental Therapeutics
  • Psychopharmacology
  • Neuropharmacology
  • ACS Chemical Neuroscience
  • The FASEB Journal

Their recent papers include:

  • "Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugs," 2020, International Journal of Drug Policy
  • "Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice," 2022, ACS Pharmacology & Translational Science
  • "Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole 'nitazene' synthetic opioid," 2022, Archives of Toxicology
  • "U-47700 and Its Analogs: Non-Fentanyl Synthetic Opioids Impacting the Recreational Drug Market," 2020, Brain Sciences
  • "First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass," 2022, Archives of Toxicology

Michael H. Baumann has collaborated frequently with a number of coauthors, including:

  • Grant C. Glatfelter
  • Donna Walther
  • Christophe P. Stove
  • David R. Manke
  • A.R. Chadeayne

Best Publications

  • Expanding global access to radiotherapy

    Rifat Atun;David A Jaffray;David A Jaffray;David A Jaffray;Michael B Barton;Freddie Bray

  • Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.

    Richard B. Rothman;Michael H. Baumann;Christina M. Dersch;Dana V. Romero

  • Diagnosis and Management of Cough Executive Summary: ACCP Evidence-Based Clinical Practice Guidelines

    Richard S. Irwin;Michael H. Baumann;Donald C. Bolser;Louis Philippe Boulet

  • Exploring the role of cancer stem cells in radioresistance.

    Michael Baumann;Mechthild Krause;Richard Hill

  • Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.

    Richard B. Rothman;Michael H. Baumann;Jason E. Savage;Laura Rauser

  • Radiation oncology in the era of precision medicine

    Michael Baumann;Mechthild Krause;Jens Overgaard;Juergen Debus

  • Monoamine transporters and psychostimulant drugs.

    Richard B. Rothman;Michael H. Baumann

  • The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue

    Michael H Baumann;Mario A Ayestas;John S Partilla;Jacqueline R Sink

  • Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.

    Michael H Baumann;John S Partilla;Kurt R Lehner;Eric B Thorndike

  • Depressive-Like Effects of the κ-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats

    William A. Carlezon;Cécile Béguin;Jennifer A. DiNieri;Michael H. Baumann

  • Hyperfractionated Accelerated Chemoradiation With Concurrent Fluorouracil-Mitomycin Is More Effective Than Dose-Escalated Hyperfractionated Accelerated Radiation Therapy Alone in Locally Advanced Head and Neck Cancer: Final Results of the Radiotherapy Cooperative Clinical Trials Group of the German Cancer Society 95-06 Prospective Randomized Trial

    Volker Budach;Martin Stuschke;Wilfried Budach;Michael Baumann

  • Caring for patients with cancer in the COVID-19 era.

    Joris van de Haar;Louisa R. Hoes;Charlotte E. Coles;Kenneth Seamon

  • Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments.

    Mechthild Krause;Anna Dubrovska;Annett Linge;Michael Baumann

  • Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer

    Daniel Zips;Klaus Zöphel;Nasreddin Abolmaali;Rosalind Perrin

  • 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings

    Michael H. Baumann;Xiaoying Wang;Richard B. Rothman

  • Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair.

    Mahmoud Toulany;Ulla Kasten-Pisula;Ingo Brammer;Shaomeng Wang

  • Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.

    Audrey Mauguen;Cécile Le Péchoux;Michele I. Saunders;Steven E. Schild

  • First clinical application of a prompt gamma based in vivo proton range verification system

    Christian Richter;Guntram Pausch;Guntram Pausch;Steffen Barczyk;Steffen Barczyk;Marlen Priegnitz

  • N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').

    Michael H Baumann;Robert D Clark;Allison G Budzynski;John S Partilla

  • Misuse of Novel Synthetic Opioids: A Deadly New Trend.

    Matthew P. Prekupec;Peter A. Mansky;Michael H. Baumann

Frequent Co-Authors

Richard B. Rothman
Richard B. Rothman National Institute on Drug Abuse
Kenner C. Rice
Kenner C. Rice National Institutes of Health
Claus Belka
Claus Belka Ludwig-Maximilians-Universität München
Richard A. Glennon
Richard A. Glennon Virginia Commonwealth University
Howard D. Thames
Howard D. Thames The University of Texas MD Anderson Cancer Center
Harald H. Sitte
Harald H. Sitte Medical University of Vienna
Marilyn A. Huestis
Marilyn A. Huestis National Institute on Drug Abuse
Jean Lud Cadet
Jean Lud Cadet National Institute on Drug Abuse
Frank Buchholz
Frank Buchholz TU Dresden
Yavin Shaham
Yavin Shaham National Institute on Drug Abuse

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in exploring alternative healthcare careers or pathways that complement your study of Medicine in the USA? There are a growing number of online degree options that can prepare you for key roles in the healthcare sector — all from the flexibility of home.

For those seeking advanced pharmacy careers, pharmd online programs offer a rigorous, accredited route to becoming a practicing pharmacist. If your interests lie in managing healthcare data, a health information technology online degree can open doors in health informatics and administration.

You can also enter the health workforce quickly through affordable medical billing and coding programs, which are ideal for those looking for practical skills in medical office operations and digital records. Aspiring nurses might consider cheap online fnp programs to advance toward a high-demand nurse practitioner role.

These online programs provide greater accessibility, often at a lower cost, and can lead to rewarding career opportunities within the broader healthcare landscape.

Best Scientists Citing Michael H. Baumann

Trending Scientists

Recently Published Articles